105 related articles for article (PubMed ID: 81949)
1. Propranolol in uraemic osteodystrophy.
Brancaccio D; Galmozzi C; Casati S; Ponticelli C
Lancet; 1978 Oct; 2(8096):940. PubMed ID: 81949
[No Abstract] [Full Text] [Related]
2. Propranolol and uraemic osteodystrophy.
Brancaccio D; Galmozzi C; Casati S; Rurale D; Belloli S; Aroldi A; Graziani G; Ponticelli C
Proc Eur Dial Transplant Assoc; 1979; 16():668-71. PubMed ID: 549007
[No Abstract] [Full Text] [Related]
3. Propranolol in uraemic osteodystrophy.
Eastwood JB
Lancet; 1979 Feb; 1(8112):386-7. PubMed ID: 85038
[No Abstract] [Full Text] [Related]
4. A possible role for propranolol in the treatment of renal osteodystrophy.
Caro JF; Besarab A; Burke JF; Glennon JA
Lancet; 1978 Aug; 2(8087):451-4. PubMed ID: 79809
[TBL] [Abstract][Full Text] [Related]
5. Practical guidelines for effective treatment of the osteodystrophic uraemic syndrome with intravenous calcitriol.
Cannella G; Moriero E; Rolla D
Nephrol Dial Transplant; 1996; 11 Suppl 3():50-3. PubMed ID: 8840313
[No Abstract] [Full Text] [Related]
6. Renal osteodystrophy and its treatment.
Duursma SA; Mees EJ
Neth J Med; 1973; 16(2):101-7. PubMed ID: 4705764
[No Abstract] [Full Text] [Related]
7. [Pharmacological suppression of hyperparathyroidism in patients treated by periodical hemodialysis. Histological, hormonal, biochemical and radiological study].
Brancaccio D; Faccini JM; Graziani G; Banfi G; Pedoja G; Watson L
Minerva Nefrol; 1976; 23(2):149-53. PubMed ID: 1087389
[No Abstract] [Full Text] [Related]
8. A trial of calcitonin therapy in renal osteodystrophy.
Delano BG; Baker R; Gardner B; Wallach S
Nephron; 1973; 11(5):287-93. PubMed ID: 4753519
[No Abstract] [Full Text] [Related]
9. Propranolol for renal osteodystrophy.
Fournier A; Coevoet B; Leroux JL; de Fremont JF; Lambrey G
Lancet; 1978 Dec 23-30; 2(8104-5):1372. PubMed ID: 82865
[No Abstract] [Full Text] [Related]
10. Long-term treatment of uraemic osteodystrophy with 1-alpha-hydroxycholecalciferol.
Nielsen SP; Binderup E; Godtfredsen WO; Jensen H; Ladefoged J
Proc Eur Dial Transplant Assoc; 1976; 12():221-6. PubMed ID: 935114
[TBL] [Abstract][Full Text] [Related]
11. Suppression of secondary hyperparathyroidism by propranolol in renal failure patients.
Besarab A; Caro JF; Ihle BU; Burke JF; Glennon JA; Fischer JA
Nephron; 1981; 27(3):127-33. PubMed ID: 7219643
[TBL] [Abstract][Full Text] [Related]
12. Myelofibrosis and renal osteodystrophy.
Weinberg SG; Lubin A; Wiener SN; Deoras MP; Ghose MK; Kopelman RC
Am J Med; 1977 Nov; 63(5):755-64. PubMed ID: 930950
[No Abstract] [Full Text] [Related]
13. Dihydrotachysterol treatment in renal osteodystrophy; the effect on alkaline and acid phosphatase.
Van Kesteren RG; Duursma SA; Dorhout Mees EJ
Neth J Med; 1978; 21(1):17-22. PubMed ID: 634412
[No Abstract] [Full Text] [Related]
14. Propranolol therapy for secondary hyperparathyroidism in uraemia.
Fournier A; Coevoet B; de Fremont JF; Gueris J; Caillens G; Desplan C; Calmette C; Moukhtar MS
Lancet; 1978 Jul; 2(8079):50-1. PubMed ID: 78252
[No Abstract] [Full Text] [Related]
15. Low-dose vitamin D analogues for renal osteodystrophy.
Lancet; 1989 Jun; 1(8651):1364-5. PubMed ID: 2567378
[No Abstract] [Full Text] [Related]
16. Use of oral and parenteral calcitriol in the treatment of renal osteodystrophy.
Coburn JW
Kidney Int Suppl; 1990 Sep; 29():S54-61. PubMed ID: 2214548
[No Abstract] [Full Text] [Related]
17. Osteodystrophy of dialysed patients treated with vitamin D.
Verberckmoes R; Bouillon R; Krempien B
Proc Eur Dial Transplant Assoc; 1973; 10(0):217-26. PubMed ID: 4370246
[No Abstract] [Full Text] [Related]
18. Vitamin D therapy in uremic osteodystrophy: theoretical and practical considerations.
Popovtzer MM
Int J Artif Organs; 1980 Jan; 3(1):1-4. PubMed ID: 7353907
[No Abstract] [Full Text] [Related]
19. Histological, hormonal, biochemical and radiological evaluation of vit. D therapy in osteodystrophy patients on RDT.
Brancaccio D; Graziani G; Faccini JM; Banfi G; Pedoja G; Watson L
J Urol Nephrol (Paris); 1976; 82(4-5):359-62. PubMed ID: 940182
[No Abstract] [Full Text] [Related]
20. [Effects of treatment with 1--alpha-hydroxyvitamin D3 in osteodystrophy in uremic patients undergoing periodical hemodialysis].
Albertazzi A; Palmieri PF; Del Rosso G; Spisni C; Evangelista M
Minerva Nefrol; 1980; 27(4):631-3. PubMed ID: 7254690
[No Abstract] [Full Text] [Related]
[Next] [New Search]
